Abstract:Objective and Impact Statement. Molecular signatures are needed for early diagnosis and improved treatment of metastatic melanoma. By high-resolution multimodal chemical imaging of human melanoma samples, we identify a metabolic reprogramming from pigmentation to lipid droplet (LD) accumulation in metastatic melanoma. Introduction. Metabolic plasticity promotes cancer survival and metastasis, which promises to serve as a prognostic marker and/or therapeutic target. However, identifying metabolic alterations has been challenged by difficulties in mapping localized metabolites with high spatial resolution. Methods. We developed a multimodal stimulated Raman scattering and pump-probe imaging platform. By time-domain measurement and phasor analysis, our platform allows simultaneous mapping of lipids and pigments at a subcellular level. Furthermore, we identify the sources of these metabolic signatures by tracking deuterium metabolites at a subcellular level. By validation with mass spectrometry, a specific fatty acid desaturase pathway was identified. Results. We identified metabolic reprogramming from a pigment-containing phenotype in low-grade melanoma to an LD-rich phenotype in metastatic melanoma. The LDs contain high levels of cholesteryl ester and unsaturated fatty acids. Elevated fatty acid uptake, but not de novo lipogenesis, contributes to the LD-rich phenotype. Monounsaturated sapienate, mediated by FADS2, is identified as an essential fatty acid that promotes cancer migration. Blocking such metabolic signatures effectively suppresses the migration capacity both in vitro and in vivo. Conclusion. By multimodal spectroscopic imaging and lipidomic analysis, the current study reveals lipid accumulation, mediated by fatty acid uptake, as a metabolic signature that can be harnessed for early diagnosis and improved treatment of metastatic melanoma.

Appliaction of fatty acid metabolism in occurrence and molecular imaging of malignant tumors

Multimodal Metabolic Imaging Reveals Pigment Reduction and Lipid Accumulation in Metastatic Melanoma

Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis

The Role of Fatty Acid Metabolism, the Related Potential Biomarkers, and Targeted Therapeutic Strategies in Gastrointestinal Cancers

Advances in fatty acid metabolism reprogramming of lung cancer

Fatty Acids in Cancer: Metabolic Functions and Potential Treatment

Fatty acid metabolism and tumor occurrence, development and metastasis

Molecular Imaging Using PET and SPECT for Identification of Breast Cancer Subtypes

Metabolic Targeting of Cancers: from Molecular Mechanisms to Therapeutic Strategies

Fatty Acid Metabolism and Cancer Development

Dysregulation of Fatty Acid Metabolism in Breast Cancer and Its Targeted Therapy

Fatty acid oxidation: An emerging facet of metabolic transformation in cancer

An Important Component of Tumor Progression: Fatty Acids

Application and Development of Deuterium Metabolic Imaging in Tumor Glucose Metabolism: Visualization of Different Metabolic Pathways

Roles of Fatty Acid Metabolism in Tumourigenesis: Beyond Providing Nutrition (Review).

Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients

Fatty Acid Synthase and Neoplasms Therapy

Fatty Acid Metabolism: A New Perspective in Breast Cancer Precision Therapy

Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring

Tumor Metabolic Reprogramming in Lung Cancer Progression.

Application of Molecular Imaging in Drug Development of Cancer